The retinoblastoma gene product is a negative modulator of the apoptotic pathway

Advances in Enzyme Regulation

Volumn 36, Issue , 1996, Pages 283-303

  Fan, Guangsheng ^a   Steer, Clifford J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; GENE PRODUCT; NUCLEAR PROTEIN; OKADAIC ACID; PROTEIN C MYC; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ANIMAL CELL; APOPTOSIS; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CONFERENCE PAPER; DRUG EFFECT; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IONIZING RADIATION; LIVER; MALE; METABOLISM; NONHUMAN; PHYSIOLOGY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE; WESTERN BLOTTING;

EID: 0030445460     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/0065-2571(95)00013-5     Document Type: Conference Paper

References (44)

1. P. W. HINDS, The retinoblastoma tumor suppressor protein, Curr. Opin. Genet. Dev. 5, 79-83 (1995).
2. R. A. WEINBERG, The retinoblastoma protein and cell cycle control, Cell 81, 323-330 (1995).
3. B. SHAN, C.-Y. CHANG, D. JONES and W.-H. LEE, The transcription factor E2F-1 mediates the autoregulation of RB gene expression, Mol. Cell. Biol. 14, 299-309 (1994).
4. J. ADNANE, Z. SHAO and P. D. ROBBINS, The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter, J. Biol. Chem. 270, 8837-8843 (1995).
5. J. Y. J. WANG, E. S. KNUDSEN and P. J. WELCH, The retinoblastoma tumor suppressor protein, Advan. Cancer Res. 64, 25-85 (1994).
6. Y. SHIIO, T. YAMAMOTO and N. YAMAGUCHI, Negative regulation of Rb expression by the p53 gene product, Proc. Natl. Acad. Sci. U.S.A. 89, 5206-5210 (1992).
7. N. E. OSIFCHIN, D. JIANG, N. OHTANI-FUJITA, T. FUJITA, M. CARROZA, S.-J. KIM, T. SAKAI and P. D. ROBBINS, Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter, J. Biol. Chem. 269, 6383-6389 (1994).
8. E. WHITE, p53, guardian of Rb, Nature 371, 21-22 (1994).
9. T. PATEL and G. J. GORES, Apoptosis and hepatobiliary disease, Hepatology 21, 1725-1741 (1995).
10. N. UEDA and S. V. SHAH, Apoptosis, J. Lab. Clin. Med. 124, 169-177 (1994).
11. P. R. WALKER, L. KOKILEVA, J. LeBLANC and M. SIKORSKA, Detection of the initial stages of DNA fragmentation in apoptosis, BioTechniques 15, 1032-1040 (1993).
12. K. L. KING and J. A. CIDLOWSKI, Cell cycle and apoptosis: common pathways to life and death, J. Cell. Biochem. 58, 175-180 (1995).
13. W. MEIKRANTZ and R. SCHLEGEL, Apoptosis and the cell cycle, J. Cell. Biochem. 58, 160-174 (1995).
14. E. Y.-H. P. LEE, C.-Y. CHANG, N. HU, Y.-C. J. WANG, C.-C. LAI, K. HERRUP, W.-H. LEE and A. BRADLEY, Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis, Nature 359, 288-294 (1992).
15. H. PAN and A. E. GRIEP, Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development, Genes Dev. 8, 1285-1299 (1994).
16. s14 induction, J. Biol. Chem. 261, 9583-9586 (1986).
17. P. SAVATIER, S. HUANG, L. SZEKELY, K. G. WIMAN and J. SAMARUT, Contrasting patterns of retinoblastoma protein expression in mouse embryonic stem cells and embryonic fibroblasts, Oncogene 9, 809-818 (1994).
18. C. A. STEIN, C. SUBASINGHE, K. SHINOZUKA and J. S. COHEN, Physicochemical properties of phosphorothioate oligodeoxynucleotides, Nucleic Acids Res. 16, 3209-3221 (1988).
19. X.-Q. QIN, T. CHITTENDEN, D. M. LIVINGSTON and W. G. KAELIN, Jr., Identification of a growth suppression domain within the retinoblastoma gene product, Genes Dev. 6, 953-964 (1992).
20. W. GORCZYCA, M. R. MELAMED and Z. DARZYNKIEWICZ, Apoptosis of S-phase HL-60 cells induced by DNA topoisomerase inhibitors: Detection of DNA strand breaks by flow cytometry using the in situ nick translation assay, Toxicol. Lett. 67, 249-258 (1993).
21. M. G. ORMEROD, X.-M. SUN, D. BROWN, R. T. SNOWDEN and G. M. COHEN, Quantification of apoptosis and necrosis by flow cytometry, Acta Oncolog. 32, 417-424 (1993).
22. F. A. OBERHAMMER, M. PAVELKA, S. SHARMA, R. TIEFENBACHER, A. F. PURCHIO, W. BURSCH and R. SCHULTE-HERMANN, Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1, Proc. Natl. Acad. Sci. U.S.A. 89, 5408-5412 (1992).
23. C. B. THOMPSON, Apoptosis in the pathogenesis and treatment of disease, Science 267, 1456-1462 (1995).
24. R. BØE, B. T. GJERTSEN, O. K. VINTERMYR, G. HOUGE, M. LANOTTE and S. O. DØSKELAND, The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells, Exptl. Cell Res. 195, 237-246 (1991).
25. M. LAIHO, J. A. DECAPRIO, J. W. LUDLOW, D. M. LIVINGSTON and J. MASSAGUÉ, Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation, Cell 62, 175-185 (1990).
26. A. S. ALBERTS, A. M. THORBURN, S. SHENOLIKAR, M. C. MUMBY and J. R. FERAMISCO, Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein by protein phosphatases, Proc. Natl. Acad. Sci. U.S.A. 90, 388-392 (1993).
27. G. FAN, R. XU, M. W. WESSENDORF, X. MA, B. T. KREN and C. J. STEER, Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes, Cell Growth Diff. 6, 1463-1476 (1995).
28. P. A. GRUPPUSO, J. E. MEAD and N. FAUSTO, Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat, Cancer Res. 50, 1464-1469 (1990).
29. S. B. JAKOWLEW, J. E. MEAD, D. DANIELPOUR, J. WU, A. B. ROBERTS and N. FAUSTO, Transforming growth factor-β (TGF-β) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-β, Cell Regul. 2, 535-548 (1991).
30. R. SCHULTE-HERMANN, W. BURSCH, B. KRAUPP-GRASL, F. OBERHAMMER, A. WAGNER and R. JIRTLE, Cell proliferation and apoptosis in normal liver and preneoplastic foci, Environ. Health Perspec. 101, 87-90 (1993).
31. G. FAN, X. MA, B. T. KREN and C. J. STEER, The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells, oncogene (in press, 1996).
32. A. E. WHITE, E. M. LIVANOS and T. D. TLSTY, Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins, Genes Dev. 8, 666-677 (1994).
33. J. R. NEVINS, E2F: a link between the Rb tumor suppressor protein and viral oncoproteins, Science 258, 424-429 (1992).
34. R. SAGER, Tumor suppressor genes in the cell cycle, Curr. Opin. Cell Biol. 4, 155-160 (1992).
35. D. A. HAAS-KOGAN, S. C. KOGAN, D. LEVI, P. DAZIN, A. T'ANG, Y.-K. T. FUNG and M. A. ISRAEL, Inhibition of apoptosis by the retinoblastoma gene product, EMBO J. 14, 461-472 (1995).
36. Y. HAUPT, S. ROWAN and M. OREN, p53-mediated apoptosis in HeLa cells can be overcome by excess pRB, Oncogene 10, 1563-1571 (1995).
37. S. D. MORGENBESSER, B. O. WILLIAMS, T. JACKS and R. A. DEPINHO, p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens, Nature 371, 72-74 (1994).
38. M. SELVAKUMARAN, H.-K. LIN, R. T. T. SJIN, J. C. REED, D. A. LIEBERMANN and B. HOFFMAN, The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor β1-induced apoptosis of myeloid leukemia cells, Mol. Cell. Biol. 14, 2352-2360 (1994).
39. D. G. JOHNSON, J. K. SCHWARZ, W. D. CRESS and J. R. NEVINS, Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature 365, 349-352 (1993).
40. J. K. SCHWARZ, C. H. BASSING, I. KOVESDI, M. B. DATTO, M. BLAZING, S. GEORGE, X.-F. WANG and J. R. NEVINS, Expression of the E2F1 transcription factor overcomes type β transforming growth factor-mediated growth suppression, Proc. Natl. Acad. Sci. U.S.A. 92, 483-487 (1995).
41. X. WU and A. J. LEVINE, p53 and E2F-1 cooperate to mediate apoptosis, Proc. Natl. Acad. Sci. U.S.A. 91, 3602-3606 (1994).
42. X.-Q. QIN, D. M. LIVINGSTON, W. G. KAELIN, Jr. and P. D. ADAMS, Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91, 10918-10922 (1994).
43. B. SHAN and W.-H. LEE, Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis, Mol. Cell. Biol. 14, 8166-8173 (1994).
44. T. F. KOWALIK, J. DEGREGORI, J. K. SCHWARZ and J. R. NEVINS, E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis, J. Virol. 69, 2491-2500 (1995).